Antimicrobial peptides: A plausible approach for COVID-19 treatment.

Pooja Rani Bhupinder Kapoor Monica Gulati Atanas Georgiev Atanasov Qushmua E Alzahrani Reena Gupta

Published in: Expert opinion on drug discovery (2022)

Although extensively investigated, successful treatment of COVID-19 is still a challenge due to emergence of virus mutants. Antiviral peptides are anticipated to be blockbuster drugs for the management of this serious infection because of their formulation and therapeutic advantages. Although they may act on different pathways, AVPs having a multi-targeted approach are considered to have the upper hand in the management of this infection.

Keyphrases

coronavirus disease
sars cov
drug delivery
atomic force microscopy
high resolution
combination therapy
mass spectrometry
single molecule
high speed